Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Jul;85(1):90-122.
doi: 10.1016/j.jinf.2022.03.024. Epub 2022 Apr 1.

Decrease of carbapenemase-producing Enterobacteriaceae incidence during the first year of the COVID-19 pandemic

Clarisse Duverger  1 , Catherine Monteil  2 , Valérie Souyri  2 , Sandra Fournier  2 ; AP-HP Infection prevention and control teams  2
Affiliations
Comment

Decrease of carbapenemase-producing Enterobacteriaceae incidence during the first year of the COVID-19 pandemic

Clarisse Duverger et al. J Infect. 2022 Jul.
No abstract available

Keywords: COVID-19; Carbapenemase-producing Enterobacteriaceae; Healthcare-associated infection; Infection control; SARS-CoV-2.

PubMed Disclaimer

Figures

Fig 1
Fig. 1
Observed carbapenemase-producing Enterobacteriaceae index cases from 2014 to 2020 and 2020 forecasted cases with 95% prediction intervals.
Fig 2
Fig. 2
Observed carbapenemase-producing Enterobacteriaceae index cases with (2A) and without (2B) a known history of stay abroad from 2014 to 2020 and 2020 forecasted cases with 95% prediction intervals.
See this image and copyright information in PMC

Comment on

References

    1. Lemenand O., Coeffic T., Thibaut S., Colomb Cotinat M., Caillon J., Birgand G., et al. Decreasing proportion of extended-spectrum beta-lactamase among E. coli infections during the COVID-19 pandemic in France. J Infect. 2021;83(6):664–670. - PubMed
    1. Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. Mar 28. - PMC - PubMed
    1. Baker M.A., Sands K.E., Huang S.S., Kleinman K., Septimus E.J., Varma N., et al. The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections. Clin Infect Dis. 2021:ciab688. - PMC - PubMed
    1. Rossato L., Negrão F.J., Simionatto S. Could the COVID-19 pandemic aggravate antimicrobial resistance? Am J Infect Control. 2020;48(9):1129–1130. Sep 1. - PMC - PubMed
    1. Murray C.J., Ikuta K.S., Sharara F., Swetschinski L., Robles Aguilar G., Gray A., et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629–655. Feb 12. - PMC - PubMed